Incannex Healthcare Inc.
IXHL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001873875
No open-market purchases or sales by Incannex Healthcare Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $1.71M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Incannex Healthcare Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 12
- −3 vs. Q1 2024
- Shares held
- 533.2K
- −107.6K (−16.8%) vs. Q1 2024
- Total value
- $1.57M
- −$727.7K (−31.7%) vs. Q1 2024
- New holders
- 1
- 3 more added
- Sold out
- 4
- 5 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IXHL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 15 | $1.71M |
| Q1 2026 | 21 | $3.87M |
| Q4 2025 | 27 | $3.34M |
| Q3 2025 | 28 | $1.76M |
| Q2 2025 | 12 | $220.2K |
| Q1 2025 | 6 | $339.3K |
| Q4 2024 | 7 | $713.8K |
| Q3 2024 | 12 | $879.5K |
| Q2 2024 | 12 | $1.57M |
| Q1 2024 | 15 | $2.30M |
| Q4 2023 | 6 | $1.26M |
| Q3 2023 | 4 | $133.3K |
| Q2 2023 | 2 | $21.5K |
| Q1 2023 | 2 | $44.2K |
| Q4 2022 | 4 | $139.1K |
| Q3 2022 | 5 | $167.0K |
| Q2 2022 | 2 | $8.00K |
| Q1 2022 | 7 | $804.0K |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Incannex Healthcare Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 2 | $6 | 0.00% | −8−80.0% | Reduced |
| Catalyst Funds Management Pty Ltd | 50 | $147 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 207 | $609 | 0.00% | −597−74.3% | Reduced |
| Macquarie Group Ltd | 598 | $1.76K | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 717 | $2.11K | 0.00% | −1,384−65.9% | Reduced |
| UBS Group AG | 6,000 | $17.6K | 0.00% | +3,076+105.2% | Added |
| Barclays PLC | 22,502 | $66.2K | 0.00% | +22,500+1,125,000.0% | Added |
| Morgan Stanley | 29,848 | $87.8K | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 43,931 | $129.0K | 0.00% | −39,041−47.1% | Reduced |
| Old Mission Capital LLC | 68,680 | $201.9K | 0.01% | +68,680 | New |
| AdvisorShares Investments LLC | 80,002 | $237.6K | 0.04% | +29,087+57.1% | Added |
| Toroso Investments, LLC | 280,616 | $825.0K | 0.01% | −142,794−33.7% | Reduced |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −20,435−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −13,726−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −10,806−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −2,134−100.0% | Sold out |